Does atenolol have an effect on calcium metabolism?

P. W.G. Brown, J. A.C. Buckels, Ashokkumar Jain, P. Mc Master

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Hypercalcaemia is often an incidental finding during biochemical investigation, being found in 1. 1% of the general population 1 and 3-6% of patients in hospital. 2 The most common cause is primary hyperparathyroidism. Ten per cent of patients with sarcoidosis have hypercalcaemia, but hypercalciuria is much more common. 3 It is therefore possible that β antagonists may be given to some patients with unsuspected disturbances in their calcium metabolism. I report on the effects of the β 1 antagonist atenolol on the calcium balance of two patients.

Original languageEnglish (US)
Pages (from-to)1324-1325
Number of pages2
JournalBritish Medical Journal (Clinical research ed.)
Volume294
Issue number6583
DOIs
StatePublished - May 23 1987

Fingerprint

Atenolol
Calcium
Hypercalcemia
Hypercalciuria
Incidental Findings
Primary Hyperparathyroidism
Sarcoidosis
Population

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Brown, P. W.G. ; Buckels, J. A.C. ; Jain, Ashokkumar ; Mc Master, P. / Does atenolol have an effect on calcium metabolism?. In: British Medical Journal (Clinical research ed.). 1987 ; Vol. 294, No. 6583. pp. 1324-1325.
@article{71260750192b490eba8b1b9728bbf2a2,
title = "Does atenolol have an effect on calcium metabolism?",
abstract = "Hypercalcaemia is often an incidental finding during biochemical investigation, being found in 1. 1{\%} of the general population 1 and 3-6{\%} of patients in hospital. 2 The most common cause is primary hyperparathyroidism. Ten per cent of patients with sarcoidosis have hypercalcaemia, but hypercalciuria is much more common. 3 It is therefore possible that β antagonists may be given to some patients with unsuspected disturbances in their calcium metabolism. I report on the effects of the β 1 antagonist atenolol on the calcium balance of two patients.",
author = "Brown, {P. W.G.} and Buckels, {J. A.C.} and Ashokkumar Jain and {Mc Master}, P.",
year = "1987",
month = "5",
day = "23",
doi = "10.1136/bmj.294.6583.1324",
language = "English (US)",
volume = "294",
pages = "1324--1325",
journal = "The BMJ",
issn = "0267-0623",
publisher = "BMJ Publishing Group",
number = "6583",

}

Does atenolol have an effect on calcium metabolism? / Brown, P. W.G.; Buckels, J. A.C.; Jain, Ashokkumar; Mc Master, P.

In: British Medical Journal (Clinical research ed.), Vol. 294, No. 6583, 23.05.1987, p. 1324-1325.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Does atenolol have an effect on calcium metabolism?

AU - Brown, P. W.G.

AU - Buckels, J. A.C.

AU - Jain, Ashokkumar

AU - Mc Master, P.

PY - 1987/5/23

Y1 - 1987/5/23

N2 - Hypercalcaemia is often an incidental finding during biochemical investigation, being found in 1. 1% of the general population 1 and 3-6% of patients in hospital. 2 The most common cause is primary hyperparathyroidism. Ten per cent of patients with sarcoidosis have hypercalcaemia, but hypercalciuria is much more common. 3 It is therefore possible that β antagonists may be given to some patients with unsuspected disturbances in their calcium metabolism. I report on the effects of the β 1 antagonist atenolol on the calcium balance of two patients.

AB - Hypercalcaemia is often an incidental finding during biochemical investigation, being found in 1. 1% of the general population 1 and 3-6% of patients in hospital. 2 The most common cause is primary hyperparathyroidism. Ten per cent of patients with sarcoidosis have hypercalcaemia, but hypercalciuria is much more common. 3 It is therefore possible that β antagonists may be given to some patients with unsuspected disturbances in their calcium metabolism. I report on the effects of the β 1 antagonist atenolol on the calcium balance of two patients.

UR - http://www.scopus.com/inward/record.url?scp=0023189386&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023189386&partnerID=8YFLogxK

U2 - 10.1136/bmj.294.6583.1324

DO - 10.1136/bmj.294.6583.1324

M3 - Article

C2 - 3109639

AN - SCOPUS:0023189386

VL - 294

SP - 1324

EP - 1325

JO - The BMJ

JF - The BMJ

SN - 0267-0623

IS - 6583

ER -